Pinnacle Associates’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-24,635
| Closed | -$602K | – | 722 |
|
|
2019
Q1 | $602K | Sell |
24,635
-4,345
| -15% | -$106K | 0.01% | 501 |
|
|
2018
Q4 | $752K | Sell |
28,980
-960
| -3% | -$24.9K | 0.02% | 445 |
|
|
2018
Q3 | $948K | Sell |
29,940
-15,975
| -35% | -$506K | 0.02% | 424 |
|
|
2018
Q2 | $1.78M | Buy |
45,915
+2,255
| +5% | +$87.6K | 0.04% | 324 |
|
|
2018
Q1 | $1.21M | Buy |
43,660
+32,560
| +293% | +$899K | 0.02% | 372 |
|
|
2017
Q4 | $201K | Buy |
+11,100
| New | +$201K | ﹤0.01% | 649 |
|